Android app on Google Play

Echo Therapeutics (ECTE) Underwriters Exercise Full Overallotment in 3.2M Offering

December 26, 2012 4:19 PM EST Send to a Friend
Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the full exercise of the over-allotment option granted to the underwriters to purchase 480,000 additional common shares, at a public offering price of $0.95 per share, in connection with its previously announced underwritten public offering of 3,200,000 shares of common stock, bringing the total gross proceeds from the offering to $3,496,000, before deducting the underwriting discount and other offering expenses payable by Echo.

Aegis Capital Corp. acted as the sole book-running manager for the offering.

Feltl and Company acted as co-manager for the offering.




You May Also Be Interested In


Related Categories

Corporate News, Equity Offerings

Add Your Comment